Angina: Introduction FeedbackA general introduction to Angina.Source: Clinical Knowledge Summaries, 01 May 2012
Angina is chest pain (or constricting discomfort) caused by an insufficient blood supply to heart muscle.
Angina is usually caused by coronary artery disease.
Less commonly, angina is caused by valve disease (for example aortic stenosis), hypertrophic obstructive cardiomyopathy, or hypertensive heart disease.
Stable angina usually occurs predictably with physical exertion or emotional stress, and is relieved within minutes of rest.
Unstable angina is new (usually within 24 hours) onset angina or abrupt deterioration in previously stable angina, often occurring at rest. Unstable angina usually requires immediate admission or referral to hospital.
Management of stable angina includes lifestyle advice:
All people who smoke should be offered advice and assisted to stop.
A cardioprotective diet should be encouraged.
Advice and support should be offered to help achieve and maintain a healthy weight if people are overweight or obese.
An increase in physical activity levels should be encouraged within the limits set by their symptoms.
Limitation of alcohol consumption should be encouraged.
Drugs used to treat angina include:
Sublingual glyceryl trinitrate (GTN) for the rapid relief of symptoms of angina and for use before performing activities known to cause symptoms of angina.
A beta-blocker or a calcium-channel blocker as first-line regular treatment to reduce the symptoms of stable angina.
Second-line treatment such as a long-acting nitrate (such as isosorbide mononitrate), nicorandil, or ivabradine.
If symptom control is poor on the maximum licensed or highest tolerated dose of one drug, another drug from a different class should be switched to or added in.
If symptom control is poor on the maximum licensed or tolerated doses of two drugs, referral to a cardiologist (for assessment for revascularization) should be arranged.
Starting a third anti-anginal drug should be considered whilst waiting for specialist assessment.
Drugs are also used for secondary prevention of cardiovascular events:
Antiplatelet treatment should be considered in all people with stable angina. For most people this will be low-dose aspirin (75 mg daily).
An angiotensin-converting enzyme (ACE) inhibitor should be prescribed for people with coexisting hypertension, heart failure, asymptomatic left ventricular dysfunction, chronic kidney disease, or previous myocardial infarction in line with current guidance, unless this is contraindicated or not tolerated. Treatment with an ACE inhibitor should be considered for people with stable angina and diabetes mellitus.
A statin should be offered in line with NICE guidance on lipid modification.
Treatment for high blood pressure should be offered in line with NICE guidance on hypertension.
Hospital admission is recommended for people presenting with the following symptoms, as they may have unstable angina:
Pain at rest (which may occur at night).
Pain on minimal exertion.
Angina that seems to be progressing rapidly despite increasing medical treatment.
Angina: Guidance FeedbackThe most relevant search results for Angina from producers of guidance information.
- Scottish Intercollegiate Guidelines Network, 29 January 2013
- Clinical Knowledge Summaries, 01 May 2012
- Stable angina
- National Institute for Health and Care Excellence, 01 July 2011
Unstable angina and NSTEMI: The early management of unstable angina and non-ST-segment-elevation myocardial infarction - guidance (CG94)National Institute for Health and Care Excellence, 01 March 2010
Chest pain of recent onset: Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin - guidance (CG95)National Institute for Health and Care Excellence, 01 March 2010
- National Institute for Health and Care Excellence, 01 August 2011
- Finnish Medical Society Duodecim, 09 December 2013
- National Institute for Health and Care Excellence, 20 September 2012
Angina: Commissioning FeedbackThe most relevant search results for Angina from producers of commissioning advice.
- National Institute for Health and Care Excellence, 01 August 2012
- QIPP, 27 November 2009
- National Institute for Health and Care Excellence, 01 November 2013
- National Institute for Health and Care Excellence, 01 May 2012
- National Institute for Health and Care Excellence, 12 August 2012
- National Institute for Health and Care Excellence, 05 September 2014
- National Institute for Health and Care Excellence, 09 September 2014
Information for the public
Angina: Information for the public FeedbackThe most relevant search results for Angina, from Department of Health accredited producers of patient information.
Angina: Ongoing Research FeedbackThe most relevant search results for Angina, from research trials.
- UK Clinical Trials Gateway, 13 September 2010
- UK Clinical Trials Gateway, 15 August 2005
- UK Clinical Trials Gateway, 21 June 2010
MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery DiseaseUK Clinical Trials Gateway, 08 November 2010
- UK Clinical Trials Gateway, 22 September 2011
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).UK Clinical Trials Gateway, 26 May 2010
Angina: Medicines FeedbackAppropriate medicines information for Angina supplied by Datapharm, a leading source of trusted, credible information about medicines.
Angina - Medicines Information
- Adalat (a brand of Nifedipine)
- Adipine (a brand of Nifedipine)
- Adizem (a brand of Diltiazem Hydrochloride)
- Angitil (a brand of Diltiazem Hydrochloride)
- Bedranol (a brand of Propranolol Hydrochloride)
- Beta-Adalat (a brand of Atenolol , a brand of Nifedipine)
- Beta-Prograne (a brand of Propranolol Hydrochloride)
- Betim (a brand of Timolol Maleate)
- Bi-Carzem (a brand of Diltiazem Hydrochloride)
- Cabren (a brand of Felodipine)
- Calchan (a brand of Nifedipine)
- Calcicard (a brand of Diltiazem Hydrochloride)
- Cardene (a brand of Nicardipine Hydrochloride)
- Cardicor (a brand of Bisoprolol Fumarate)
- Cardioplen (a brand of Felodipine)
- Chemydur (a brand of Isosorbide Mononitrate)
- Cibral (a brand of Isosorbide Mononitrate)
- Coracten (a brand of Nifedipine)
- Cordilox (a brand of Verapamil Hydrochloride)
- Corgard (a brand of Nadolol)
- Dilcardia (a brand of Diltiazem Hydrochloride)
- Dilzem (a brand of Diltiazem Hydrochloride)
- Emcor (a brand of Bisoprolol Fumarate)
- Felendil (a brand of Felodipine)
- Felogen (a brand of Felodipine)
- Felotens (a brand of Felodipine)
- Fortipine (a brand of Nifedipine)
- Glyceryl Trinitrate
- Horizem (a brand of Diltiazem Hydrochloride)
- Hypolar (a brand of Nifedipine)
- Ikorel (a brand of Nicorandil)
- Isoket (a brand of Isosorbide Dinitrate)
- Isosorbide Dinitrate
- Isosorbide Mononitrate
- Istin (a brand of Amlodipine)
- Ivabradine (a generic version of Procoralan)
- Kentipine (a brand of Nifedipine)
- Kenzem (a brand of Diltiazem Hydrochloride)
- Monomil (a brand of Isosorbide Mononitrate)
- Monosorb (a brand of Isosorbide Mononitrate)
- Neofel (a brand of Felodipine)
- Nifopress (a brand of Nifedipine)
- Parmid (a brand of Felodipine)
- Pinefeld (a brand of Felodipine)
- Ranexa (a brand of Ranolazine)
- Retalzem (a brand of Diltiazem Hydrochloride)
- Sectral (a brand of Acebutolol Hydrochloride)
- Securon (a brand of Verapamil Hydrochloride)
- Slozem (a brand of Diltiazem Hydrochloride)
- Syprol (a brand of Propranolol Hydrochloride)
- Tensipine (a brand of Nifedipine)
- Tildiem (a brand of Diltiazem Hydrochloride)
- Transiderm-Nitro (a brand of Glyceryl Trinitrate)
- Trasicor (a brand of Oxprenolol Hydrochloride)
- Triapin (a brand of Felodipine , a brand of Ramipril)
- Univer (a brand of Verapamil Hydrochloride)
- Vascalpha (a brand of Felodipine)
- Vera-Til (a brand of Verapamil Hydrochloride)
- Vertab (a brand of Verapamil Hydrochloride)
- Viazem (a brand of Diltiazem Hydrochloride)
- Visken (a brand of Pindolol)
- Xismox (a brand of Isosorbide Mononitrate)
- Zemtard (a brand of Diltiazem Hydrochloride)
- Zolvera (a brand of Verapamil Hydrochloride)
- Results are currently sorted by relevance (Sort results by: date)
- Results 1 - 10 (of 11946)
...In Twitter Facebook Email More... Angina Angina D000787Angina Pectoris D060050Angina, Stable...Cardiovascular 2012-05-01Last revised in September 2014 Angina - Summary Angina is chest pain (or constricting...
Clinical Knowledge Summaries, 01 May 2012
Ivabradine (Procoralan) in the symptomatic treatment of angina: risk of cardiac side effects—new advice to minimise risk
...Procoralan) in the symptomatic treatment of angina: risk of cardiac side effects—new advice...heart failure and the symptoms of chronic angina in adults unsuited to or unable to take...049 participants who had symptomatic angina. In this subgroup, there was a small...
Medicines and Healthcare products Regulatory Agency, 18 December 2014
...for the diagnosis and management of angina and myocardial infarction (NICE technology appraisal guidance 73). Angina is pain or constricting discomfort...discomfort, breathlessness or nausea. Angina is the main symptom of myocardial ischaemia...
National Institute for Health and Care Excellence, 01 July 2011
...recommendations for the early management of unstable angina and NSTEMI from NICE technology appraisal...encompasses a range of conditions from unstable angina to ST-segment-elevation myocardial...addresses the early management of unstable angina and non-ST-segment-elevation myocardial...
National Institute for Health and Care Excellence, 01 March 2010
...revascularisation (TMLR) for refractory angina pectoris shows no efficacy, based on...Indications and current treatments 2.1.1 Angina pectoris is chest discomfort, often described...of coronary artery disease. Refractory angina is a severe angina form that cannot be...
National Institute for Health and Care Excellence, 01 May 2009
...revascularisation (PLR) for refractory angina pectoris shows no efficacy and suggests...Indications and current treatments 2.1.1 Angina pectoris is chest discomfort, often described...of coronary artery disease. Refractory angina is a severe angina form that cannot be...
National Institute for Health and Care Excellence, 01 May 2009
National Institute for Health and Care Excellence - Publication type: Pathway, Guidance
Management of stable angina A national clinical guideline 1...cardiology and cardiac surgery 12 5 Stable angina and non-cardiac surgery 19 6 Psychological...Guidelines Network Management of stable angina A national clinical guideline February...
Scottish Intercollegiate Guidelines Network, 01 February 2007
...Traditional Chinese herbal products for stable angina Qi Zhuo 1 , Zhengyong Yuan 2...Traditional Chinese herbal products for stable angina. Cochrane Database of Systematic Reviews...of support Notes Index terms Angina pectoris is the most common clinical manifestation...
Cochrane Database of Systematic Reviews, 12 May 2010 - Publisher: John Wiley & Sons, Ltd
...external counterpulsation for chronic angina pectoris Fawzi Amin 1,* , Amani...external counterpulsation for chronic angina pectoris. Cochrane Database of Systematic...muscle and causing the classic pain of angina pectoris. It has been estimated to affect...
Cochrane Database of Systematic Reviews, 17 February 2010 - Publisher: John Wiley & Sons, Ltd
Searches related to “Angina”
- Areas of interest
Types of information
Select one or more of the 'type of information' options below to narrow your search
- Commissioning Guides(14)
- Drug / Medicines Management(442)
- Drug Best Practice Guidance(54)
- Drug Horizon Scanning(57)
- Drug Prescribing and Safety(2265)
- Drug Regulatory and Marketing(81)
- Evidence Summaries(2278)
- Health Technology Assessments(649)
- Known Uncertainties(37)
- Medicines Current Awareness(64)
- Ongoing Trials(124)
- Patient Information(4198)
- Policy and Service Development(139)
- Population Intelligence(15)
- Population Needs Assessments(2)
- Primary Research(244)
- Quality Measures(14)
- Systematic Reviews(652)
Start typing a Source name to narrow your search, or select one or more from the A-Z list
- Age UK(3)
- All Wales Medicines Strategy Group - AWMSG (9)
- American College of Gastroenterology(1)
- Arthritis Research UK (5)
- Association of Anaesthetists of GB and Ireland - AAGBI (4)
- Asthma UK (1)
- Beating Bowel Cancer(1)
- BestBETS (68)
- Brain and Spine Foundation (1)
- Breast Cancer Care (1)
- British Association for Psychopharmacology - BAP (2)
- British Association for Sexual Health and HIV - BASHH (1)
- British Association of Dermatologists - BAD (2)
- British Committee for Standards in Haematology - BCSH (5)
- British Dietetic Association - BDA (1)
- British Geriatrics Society - BGS (1)
- British Lung Foundation - BLF(1)
- British Medical Association - BMA (1)
- British National Formulary - BNF (207)
- British National Formulary for Children - BNFc (21)
- British Nuclear Medicine Society - BNMS (4)
- British Pain Society - BPS (1)
- British Society for Sexual Medicine - BSSM (1)
- British Society of Audiology (1)
- British Society of Gastroenterology - BSG (3)
- British Thoracic Society - BTS (5)
- British Transplantation Society (1)
- Bupa (26)
- Cancer Research UK (77)
- Centre for Health Economics - CHE(3)
- Centre for Mental Health (3)
- Centre for Reviews and Dissemination Health Technology Assessments - CRD HTA (47)
- Children's Heart Federation(1)
- Clinical Knowledge Summaries - CKS (48)
- Cochrane Central Register of Controlled Trials(67)
- Cochrane Database of Systematic Reviews (261)
- College of Emergency Medicine - CEM (3)
- Database of Abstracts of Reviews of Effects - DARE (271)
- Department of Health(4)
- Department of Health Western Australia - Diagnostic Imaging Pathways(2)
- electronic Medicines Compendium - eMC (2387)
- ENT UK(1)
- European Association of Urology - EAU (6)
- European Centre for Disease Prevention and Control(4)
- European Medicines Agency - EMA(85)
- European Monitoring Centre for Drugs and Drug Addiction(2)
- European Society for Medical Oncology - ESMO(2)
- European Society of Cardiology - ESC (8)
- Faculty of Public Health - FPH (1)
- Faculty of Sexual and Reproductive Healthcare (2)
- Family Planning Association(1)
- Finnish Medical Society Duodecim(5)
- Guidelines and Audit Implementation Network - GAIN (3)
- Healthcare Improvement Scotland(24)
- Healthcare Quality Improvement Partnership - HQIP (20)
- Healthtalkonline (2788)
- Indicators for Quality Improvement - IQI (2)
- Joseph Rowntree Foundation - JRF (1)
- King’s Fund (3)
- Macmillan Cancer Support(1)
- Medicines and Healthcare products Regulatory Agency - MHRA(603)
- Motor Neurone Disease Association(1)
- Multiple Sclerosis Trust - MS Trust(1)
- National Audit Office - NAO (4)
- National Cancer Institute, USA(1)
- National Institute for Health and Care Excellence - NICE (229)
- National Travel Health Network and Centre - NaTHNaC (1)
- New Drugs Online - NDO (20)
- NHS Choices(25)
- NHS Economic Evaluation Database - NHS EED (222)
- NHS England(7)
- NHS Improving Quality(1)
- NIHR Horizon Scanning Centre - NIHR HSC (34)
- NIHR Journals Library - Health Services and Delivery Research(11)
- NIHR Journals Library - Health Technology Assessment(354)
- NIHR Journals Library - Programme Grants for Applied Research(1)
- Nuffield Trust (1)
- Parkinson's UK(2)
- Patient UK(2073)
- Public Health England(16)
- Public Health Wales(1)
- Renal Association (2)
- Royal College of Anaesthetists (4)
- Royal College of Nursing - RCN (7)
- Royal College of Ophthalmologists (6)
- Royal College of Physicians of London - RCP(7)
- Royal College of Psychiatrists - RCPsych (4)
- Royal College of Radiologists - RCR (1)
- Royal College of Surgeons - RCS (2)
- SCIE Social Care Online(5)
- Scottish Intercollegiate Guidelines Network - SIGN (21)
- Scottish Medicines Consortium - SMC (10)
- Stroke Association (9)
- Terrence Higgins Trust(2)
- UK Clinical Trials Gateway - UKCTG(64)
- UK Database of Uncertainties about the Effects of Treatments - UK DUETS (37)
- US Food and Drug Administration - FDA(7)
- Welsh Medicines Resource Centre - WeMeReC(3)
- WHO Health Evidence Network (2)
- WHO Regional Office for Europe - WHO Europe (26)
- World Gastroenterology Organisation - WGO (1)
- World Health Organization(11)
Medicines and devices
Start typing a Medicine or device name to narrow your search, or select one or more from the A-Z list
- Ascorbic acid(7)
- Dabigatran etexilate(6)
- Epoetin beta(6)
- Fish oil(11)
- Folic acid(17)
- Fusidic acid(6)
- Glyceryl trinitrate(34)
- Inositol nicotinate(8)
- Insulin glargine(15)
- Interferon alfa-2a(11)
- Interferon gamma(7)
- Irbesartan + hydrochlorothiazide(8)
- Isosorbide dinitrate(15)
- Isosorbide mononitrate(26)
- Losartan + hydrochlorothiazide(6)
- Nicotinic acid(6)
- Nitric oxide(6)
- Peginterferon alfa-2a(10)